Holen Sie sich die Stockscreener-App
359.58
0.16%
-0.58
Handel nachbörslich:
359.58
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
Insider Sell: Louis Sullivan Sells 26,209 Shares of United Thera - GuruFocus.com
United Therapeutics Co. (NASDAQ:UTHR) Director Sells $9,781,722.98 in Stock - MarketBeat
United Therapeutics director sells shares worth $9.78 million - Investing.com
United Therapeutics president and COO sells $3.7 million in stock - Investing.com India
United Therapeutics (NASDAQ:UTHR) Trading Down 4.4%Here's Why - MarketBeat
United Therapeutics 'no longer pursuing' nearly 350 acres in Hackett Hill area - The Union Leader
United Therapeutics president and COO sells $3.7 million in stock By Investing.com - Investing.com UK
United Therapeutics Makes History: First-Ever Genetically Modified Pig Kidney Transplant Success - StockTitan
United Therapeutics cancels plans to buy Hackett Hill property from Manchester - New Hampshire Business Review
Franklin Resources Inc. Grows Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Tidal Investments LLC Acquires 2,803 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Lord Abbett & CO. LLC Buys 46,170 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Oddo BHF Asset Management Sas Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Geode Capital Management LLC Purchases 45,566 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Tri Ri Asset Management Corp Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
iA Global Asset Management Inc. Lowers Stock Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics president sells $3.45 million in stock By Investing.com - Investing.com Canada
United Therapeutics president sells $3.45 million in stock - Investing.com
Brophy Wealth Management LLC Invests $809,000 in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
With EPS Growth And More, United Therapeutics (NASDAQ:UTHR) Makes An Interesting Case - Simply Wall St
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Worldquant Millennium Advisors LLC - MarketBeat
State Street Corp Decreases Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Dorsey Wright & Associates Purchases New Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) EVP Sells $2,882,649.00 in Stock - MarketBeat
United Therapeutics' EVP sells $2.88 million in stock - Investing.com India
United Therapeutics' EVP sells $2.88 million in stock By Investing.com - Investing.com Canada
United Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by Chevy Chase Trust Holdings LLC - MarketBeat
Janus Henderson Group PLC Acquires 50,409 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 1,531 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Parkman Healthcare Partners LLC - MarketBeat
PDT Partners LLC Reduces Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Edgestream Partners L.P. Buys New Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $76.21 Million Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
PH-ILD Pipeline 2024: Clinical Trials Assessment, FDA - openPR
45,266 Shares in United Therapeutics Co. (NASDAQ:UTHR) Acquired by Erste Asset Management GmbH - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Has $10.44 Million Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
BNP Paribas Financial Markets Has $12.25 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
True Wealth Design LLC Sells 3,274 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Cerity Partners LLC Acquires 4,005 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Fmr LLC Acquires 314,004 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Bank of Montreal Can - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Martingale Asset Management L P - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Holdings Trimmed by Crawford Fund Management LLC - MarketBeat
The 3.8% return this week takes United Therapeutics' (NASDAQ:UTHR) shareholders five-year gains to 314% - Yahoo Finance
United Therapeutics Co. (NASDAQ:UTHR) Shares Bought by Bridgewater Associates LP - MarketBeat
Glenmede Trust Co. NA Boosts Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics president sells shares worth $3.73 million By Investing.com - Investing.com Nigeria
Dai ichi Life Insurance Company Ltd Sells 1,412 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) COO Sells 10,000 Shares of Stock - MarketBeat
United Therapeutics president sells shares worth $3.73 million - Investing.com
Loomis Sayles & Co. L P Sells 83,408 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Pulmonary Arterial Hypertension Market Is Expected To Reach Revenue Of USD 13.2 Bn By 2033, At 5.6% CAGR: Dimension Market Research. - Yahoo Finance
Idiopathic Pulmonary Fibrosis Market Report 2034, by DelveInsight | Companies: FibroGen, Hoffmann-La Roche Ltd, United Therapeutics, Boehringer Ingelheim, Pliant Therapeutics, Inc., Galecto Biotech - The Globe and Mail
Charles Schwab Investment Management Inc. Sells 17,838 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Swedbank AB Decreases Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
0.43%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):